Neurology

AAIC 2026: Alzheimer’s Association International Conference

Date: July 12-15, 2026

Location: London, United Kingdom

Quanterix is proud to participate in AAIC 2026 from July 12-15, 2026 in London, UK. AAIC is the world’s largest international conference dedicated to advancing dementia science and clinical practice. Hosted by the Alzheimer’s Association, the event gathers leading researchers, clinicians, early career investigators, and care professionals from around the globe to share the latest breakthroughs in Alzheimer’s and dementia research through presentations, posters, workshops, and networking opportunities. Whether attending in person or online, participants will engage with cutting-edge science and collaborate to accelerate progress toward better diagnosis, treatment, and care.

Discover LucentAD^® Complete

LucentAD^® Complete by Lucent Diagnostics, a Quanterix brand, is a highly sensitive blood test that measures multiple Alzheimer’s related biomarkers, including p-Tau 217, AB 42/40, GFAP, and NfL. This multi-analyte algorithmic approach reduces the diagnostic uncertainty associated with single biomarker tests, making it an essential tool for earlier Alzheimer’s disease evaluation.

Learn more

Join us for our poster presentations

On July 12 and July 15, David Wilson, VP, Clinical Strategy and Diagnostics, will present the following posters:

#13861: Multi-Analyte Plasma Risk Score Improves Sensitivity and Certainty for Early AD Detection In a Diverse Community-Based Cohort
#13875: Beyond the p-Tau 217 Snapshot: Multi-Analyte Plasma Risk Score Resolves the ‘Shadow Zone’ of Leading-Edge Alzheimer’s Pathology
#13879: Controlled Head-to-Head Comparison of p-Tau 217, p-Tau 217/AB42 Ratio, and Multi-Analyte Blood Tests in a Diverse Community-Based Cohort
#6379: Comparative Performance Analysis of a Multi-Analyte Algorithmic Immunoassay in a Defined Cross-sectional and Longitudinal ADNI Cohort